Variation in <i>SIPA1L2</i> is correlated with phenotype modification in Charcot– Marie– Tooth disease type 1A
Feifei Tao(University of Miami), Stephan Züchner(University of Miami), Gary W. Beecham(University of Miami), Mary M. Reilly(University College London), Sabrina W. Yum(Children's Hospital of Philadelphia), Camila Lopez‐Anido(University of Wisconsin–Madison), John Svaren(University of Wisconsin–Madison), Michael E. Shy(University of Iowa), Mario Saporta(University of Miami), Susan H. Blanton(University of Miami), Devon Rizzo(University of South Florida), Frank Baas(The Netherlands Cancer Institute), Thomas E. Lloyd(Johns Hopkins University), Byung‐Ok Choi(Yonsei University), Davide Pareyson(Unknown), Adriana Rebelo(University of Miami), Jasper M. Morrow(National Hospital for Neurology and Neurosurgery), Shawna Feely(Wayne State University), Camiel Verhamme(Unknown), John J. Moran(University of Wisconsin–Madison), Franco Taroni(Fondazione IRCCS Istituto Neurologico Carlo Besta), Jun Li(Wayne State University), David N. Herrmann(University of Rochester Medical Center), Lisa Abreu(University of Miami), Charlotte J. Sumner(Johns Hopkins University), Callyn A. Kirk(University of South Florida), Xingyao Wu(University of Iowa), Steven S. Scherer(University of Pennsylvania)
Cited by 45
Related Papers
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
|Annals of Neurology|2010|728
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691